220 likes | 363 Vues
London cancer workshop 15 th March 2011 . Agenda. Objectives . To inform providers of the implementation programme To engage providers in the development of the provider network model and specification
E N D
Objectives • To inform providers of the implementation programme • To engage providers in the development of the provider network model and specification • To outline to providers the timeframe for specification development and provider network bids • To prompt providers to begin provider network discussions and bid development
Developing the proposals • 45 clinicians working over 12 months • Three work areas: early diagnosis; common cancers and general care; rarer cancers and specialist care • Case for change: December 2009 • Model of care: August 2010 • Extensive 3-month engagement on proposals – over 85 per cent of survey respondents supportive
The case for change • Later diagnosis has been a major factor in causing poorer relative survival rates • There are areas of excellence in London but inequalities in access and outcomes exist • Treatment and care should be standardised • Specialist surgery should be centralised: common treatments should be localised where possible • Comprehensive pathways should be commissioned; organisational boundaries should not be a barrier
The model of care • Improve early diagnosis by addressing public awareness, GP access to diagnostics, screening uptake rates and health inequalities • Extended local provision of common cancer services, such as chemotherapy, non-complex surgery and acute oncology • Further consolidation of surgical services for rarer cancers into specialist centres • A small number of networks of providers delivering standardised pathways
Provider networks • Model of care recommends the split of commissioning and provider networks • Provider networks to deliver comprehensive pathways in response to fragmentation of services • Concept right but language of networks clouds issue • Integrated cancer systems containing all NHS organisations delivering cancer services from diagnosis to end of life care
Workstream Phase one Phase two Phase three Dec 10 – Mar 11 Apr 11 – Mar 12 Apr 12 – Mar 13 1. Public health and primary care 2. Best practice 3. Radiotherapy commissioning 4. Integrated system designation 5. Integrated system development Implementation workstreams
Integrated system designation • Providers will be asked to respond collaboratively to a integrated system specification • There will be more than one and fewer than five • Which system they are in will be the provider’s choice • Only providers in a system will provide cancer services • Legal status required for contracting
Services • Integrated systems will be required to demonstrate how they will contribute to the delivery of the model of care: • Early diagnosis • General care • Common cancer • Rarer cancers and specialist care
Specification • In addition to services, the integrated system specification will cover 6 areas: • Scope • Governance • Information • Incentives • Culture • Research and education
Standards • Commissioners will set measures and thresholds to assure quality and drive excellence
Incentives • Money • Commissioning incentives • Within integrated system • E.g. stroke tariff • Workforce • Cross boundary working • Clinical leadership • Reputation • Of system versus of organisation • Performance info across pathway
The givens • We will change the way we commission to commissioning by pathways • Only those part of an integrated system will provide cancer services • Will contain as a minimum all secondary and tertiary care providers • Some pathways will cross systems • Will demonstrate commitment to implementing model of care for common and rarer cancer services • Clinically led with an overarching governance board will manage system as single entity
The givens • We will change the way we commission to commissioning by pathways • Only those part of an integrated system will provide cancer services • Will contain as a minimum all secondary and tertiary care providers • Some pathways will cross systems • Will demonstrate commitment to implementing model of care for common and rarer cancer services • Clinically led with an overarching governance board will manage system as single entity
Group session – internal info Tables 1 and 3 • How will the system track patients between its constituent parts? • How will clinical information be shared across the system to manage patients along the care pathway? • Will there be any information governance issues and how might these be managed? • What are the potential barriers to the collection and sharing of this information?
Group session – performance info Tables 2 and 4 • What information will the governance board need to ensure performance of the system as a whole? • How will the governance board ensure that data is comparable across the system? • What information will commissioners need to be assured that comprehensive pathways delivered? • What are the potential barriers to the collection and sharing of this information?
Next steps • Ongoing work in March on commissioning an integrated system • Outline specification published in April • Ongoing development of the model beyond April • Bidding stage from April to June • Tailored support available during bid development • For further information on the case for change and model of care visit www.csl.nhs.uk/publications